Klemera-Doubal biological age acceleration

Biomarker

2 papers2 findings

  • Humans2

Effects

1

Chronic obstructive pulmonary disease

mediatesin humans1

1 study
  1. Klemera-Doubal biological age acceleration mediates chronic obstructive pulmonary disease in humans (14.3% mediated).

    “KDM-BAAc mediated 14.3% (fully adjusted) of smoking's effect on COPD.”

    Humanssmoking-COPD relationshipmean 3.4 yearsn = 1,269

    Biological aging, a mediator between smoking and chronic obstructive pulmonary disease: evidence from a hospital-based cohort study in China

    BMC pulmonary medicine10 Jan 2026

More on Chronic obstructive pulmonary disease

Associations

1

Chronic obstructive pulmonary disease

upin humans1HR 1.07

1 study
  1. Klemera-Doubal biological age acceleration raises the risk of chronic obstructive pulmonary disease in humans (HR = 1.07, 95% CI = 1.03-1.12).

    “Each 1-year increase in KDM-BAAc elevated COPD risk by 7% [fully adjusted hazard ratio (HR) = 1.07, 95% CI = 1.03-1.12].”

    Humansmean 3.4 yearsn = 1,269

    Biological aging, a mediator between smoking and chronic obstructive pulmonary disease: evidence from a hospital-based cohort study in China

    BMC pulmonary medicine10 Jan 2026

More on Chronic obstructive pulmonary disease

Latest

Nov 2025: 1Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 03 in 12 months
Frontiers in Public Health

Arterial stiffness is linked to incident sarcopenia

The highest arterial stiffness tertile had higher risks of sarcopenia (HR 1.56) and probable sarcopenia (HR 1.38) compared with the lowest tertile.The highest arterial stiffness tertile had higher risks of sarcopenia (HR 1.56) and probable sarcopenia (HR 1.38) compared with the lowest tertile.

Cohort study of 32,451 peopleSarcopenia